“The Wall Street Journal is reporting that Pfizer is planning to cut their shipment of Covid-19 vaccines for 2020 in half due to supply-chain problems,” writes Slashdot reader phalse phace. Axios (non-paywalled source) reports: The U.K. government has ordered 40 million doses of Pfizer-BioNTech’s vaccine — enough to inoculate some 20 million people. The companies now expect to ship 50 million vaccines by the end of 2020, per WSJ. “Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021,” Pfizer spokesperson Kim Bencker told Axios.
“[S]caling up a vaccine at this pace is unprecedented, and we have made significant progress as we have moved forwards in the unknown,” Bencker said. “And it’s important to highlight that the outcome of the clinical trial was somewhat later than the initial projection requiring us to focus additional efforts on clinical trial production.” Pfizer did not specify to the Journal what shortfalls over ingredients and raw materials — which were sourced from Europe and the U.S. — took place as production ramped up. For the record, Pfizer’s vaccine has been shown to be more than 90% effective.
Read more of this story at Slashdot.